Resumen documental de ASEM
Official National Advisory Committee on Immunization document (2023) on “Recombinant influenza vaccines: A supplemental statement of the Canadian Immunization Guide chapter on influenza and statement on seasonal influenza vaccine for 2022–2023”. The objective of this statement is to review the available evidence on the efficacy, effectiveness, immunogenicity, and safety of Supemtek, and to provide guidance on its use among adults in Canada.
Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.
Documento oficial